| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5901903 | Journal of Diabetes and its Complications | 2016 | 25 Pages |
Abstract
In this specific population, empagliflozin in combination with other oral agents, significantly reduced HbA1c and body weight and was well tolerated.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Irene Romera, Ramon Gomis, Susanne Crowe, Pedro de Pablos-Velasco, Unai Aranda, Arantxa GarcÃa, Sanja Giljanovic Kis, Ebrahim Naderali,